Examples of using Antithrombin in English and their translations into Spanish
{-}
-
Colloquial
-
Official
Hereditary antithrombin deficiency can be divided into type I
Frequent antithrombin activity assessments and dosing adjustments may be necessary when starting treatment
No antibodies to antithrombin alfa have been detected up to 90 days following treatment with ATryn.
The archetypal example of this situation is antithrombin, which circulates in plasma in a partially inserted relatively inactive state.
Binding of heparin or HS to AT has been shown to increase the anti-coagulant activity of antithrombin 1000 fold.
Antithrombin deficiency generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism.
Mutations that cause type II coding result of altered antithrombin protein with reduced activity.
Other studies in progress involve the use of albumin in hepatology and antithrombin in heart surgery.
Treatment should be initiated under the supervision of a physician experienced in the treatment of patients with congenital antithrombin deficiency.
Within heparin and heparin sulfate this monomeric sequence is thought to form the high-affinity binding site for the anti-coagulant factor antithrombin AT.
An antithrombin deficiency is one of the risk factors for venous thromboembolism since antithrombin is a powerful natural anticoagulant that acts mainly by inhibiting thrombin(factor IIa)
The GATRA program(Grifols Antithrombin Research Awards)
This gene encodes a protein called antithrombin(formerly known as antithrombin III), one type of serine protease inhibitor(serpin)
Thus, concurrent administration of antithrombin with heparin, low molecular weight heparin, or other anticoagulants that potentiate the anticoagulant activity of antithrombin to a patient with increased risk of bleeding must be monitored clinically and biologically.
In a formal clinical trial employing serial Duplex ultrasound examinations, antithrombin alfa was shown to be effective in the prevention of thromboembolic events in fourteen congenital antithrombin deficient patients in clinical high risk situations.
Complex glycoproteins such as monoclonal antibodies or antithrombin cannot be produced by genetically engineered bacteria,
Use in antithrombin III deficiency FFP can be used as a source of antithrombin III in patients who are deficient of this inhibitor and are undergoing surgery or who require heparin for treatment of thrombosis.
Individuals with an inherited deficiency of antithrombin type IIb have a lower risk of formation of an abnormal blood clot that persons with other forms, because the antithrombin protein is capable of inactivating coagulation proteins without heparin.
Or hypercoagulability, is a greater predisposition for the formation of blood clots that is caused by a decrease in the levels of antithrombin III in the blood due to its loss in urine.
related compounds increase the action of antithrombin on thrombin and factor Xa.